Literature DB >> 14661935

Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement.

Ingrid J Castellanos1, Kai Griebenow.   

Abstract

PURPOSE: To investigate the potential of different solvents with better biocompatibility to replace CH2Cl2 in the encapsulation of alpha-chymotrypsin in poly (lactic-co-glycolic) acid (PLGA) microspheres without causing protein instability.
METHODS: The oil-to-water (O:W) ratio in the emulsification step of the solid-in-oil-in-water (s/o/w) encapsulation process was optimized with respect to maximizing protein stability and encapsulation efficiency for various solvents. Formation of insoluble aggregates and residual enzyme activity were primarily used as stability parameters. Several solvents possessing low toxicity with different water solubility were used to prepare alpha-chymotrypsin loaded PLGA microspheres.
RESULTS: The O:W ratio in the emulsification step is critical with respect to maintaining protein stability. This was related to the solvents' water solubility. In general, hydrophilic solvents were detrimental to protein stability and encapsulation efficiency. However, after optimization of the O:W ratio for solvents with different water solubility, protein stability was preserved during encapsulation using butyl acetate when poly (ethylene glycol) (PEG) was used as the emulsifying agent (ca. 1% of non-covalent aggregates and 93 +/- 10% of residual specific activity).
CONCLUSIONS: The s/o/w technique was successfully improved by replacing the ICH class 2 solvent CH2Cl2 with the class 3 solvent butyl acetate without compromising alpha-chymotrypsin stability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661935     DOI: 10.1023/b:pham.0000003388.59659.fa

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique.

Authors:  I J Castellanos; K G Carrasquillo; J D López; M Alvarez; K Griebenow
Journal:  J Pharm Pharmacol       Date:  2001-02       Impact factor: 3.765

2.  In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres.

Authors:  M J Blanco-Príeto; K Besseghir; O Zerbe; D Andris; P Orsolini; F Heimgartner; H P Merkle; B Gander
Journal:  J Control Release       Date:  2000-06-15       Impact factor: 9.776

3.  Relationship between conformational stability and lyophilization-induced structural changes in chymotrypsin.

Authors:  K G Carrasquillo; C Sanchez; K Griebenow
Journal:  Biotechnol Appl Biochem       Date:  2000-02       Impact factor: 2.431

4.  On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer.

Authors:  K G Carrasquillo; H R Costantino; R A Cordero; C C Hsu; K Griebenow
Journal:  J Pharm Sci       Date:  1999-02       Impact factor: 3.534

5.  Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

Authors:  P Johansen; Y Men; R Audran; G Corradin; H P Merkle; B Gander
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

6.  A novel method of preparing PLGA microcapsules utilizing methylethyl ketone.

Authors:  H Sah; M S Smith; R T Chern
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

7.  Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristics.

Authors:  K S Soppimath; A R Kulkarni; T M Aminabhavi
Journal:  Drug Dev Ind Pharm       Date:  2001-07       Impact factor: 3.225

8.  Encapsulation-induced aggregation and loss in activity of gamma-chymotrypsin and their prevention.

Authors:  Ingrid J Castellanos; Gloydian Cruz; Rubén Crespo; Kai Griebenow
Journal:  J Control Release       Date:  2002-06-17       Impact factor: 9.776

9.  Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.

Authors:  D T Birnbaum; J D Kosmala; D B Henthorn; L Brannon-Peppas
Journal:  J Control Release       Date:  2000-04-03       Impact factor: 9.776

10.  Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

Authors:  J M Péan; F Boury; M C Venier-Julienne; P Menei; J E Proust; J P Benoit
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

View more
  5 in total

1.  Moisture-induced solid state instabilities in alpha-chymotrypsin and their reduction through chemical glycosylation.

Authors:  Giselle M Flores-Fernández; Miraida Pagán; Mariangely Almenas; Ricardo J Solá; Kai Griebenow
Journal:  BMC Biotechnol       Date:  2010-08-09       Impact factor: 2.563

2.  Glycosylation improves α-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic)acid microspheres.

Authors:  Giselle M Flores-Fernández; Kai Griebenow
Journal:  Results Pharma Sci       Date:  2012

Review 3.  Solid-in-Oil-in-Water Emulsion: An Innovative Paradigm to Improve Drug Stability and Biological Activity.

Authors:  Anali Sawant; Seema Kamath; Hemanth Kg; Girish Pai Kulyadi
Journal:  AAPS PharmSciTech       Date:  2021-07-01       Impact factor: 3.246

4.  Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres.

Authors:  Moraima Morales-Cruz; Giselle M Flores-Fernández; Myreisa Morales-Cruz; Elsie A Orellano; José A Rodriguez-Martinez; Mercedes Ruiz; Kai Griebenow
Journal:  Results Pharma Sci       Date:  2012

5.  Activation of caspase-dependent apoptosis by intracellular delivery of Cytochrome c-based nanoparticles.

Authors:  Moraima Morales-Cruz; Cindy M Figueroa; Tania González-Robles; Yamixa Delgado; Anna Molina; Jessica Méndez; Myraida Morales; Kai Griebenow
Journal:  J Nanobiotechnology       Date:  2014-09-02       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.